1. Home
  2. AVDL vs ROG Comparison

AVDL vs ROG Comparison

Compare AVDL & ROG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AVDL
  • ROG
  • Stock Information
  • Founded
  • AVDL 2015
  • ROG 1832
  • Country
  • AVDL Ireland
  • ROG United States
  • Employees
  • AVDL N/A
  • ROG N/A
  • Industry
  • AVDL Biotechnology: Pharmaceutical Preparations
  • ROG Industrial Machinery/Components
  • Sector
  • AVDL Health Care
  • ROG Technology
  • Exchange
  • AVDL Nasdaq
  • ROG Nasdaq
  • Market Cap
  • AVDL 1.5B
  • ROG 1.5B
  • IPO Year
  • AVDL 1996
  • ROG N/A
  • Fundamental
  • Price
  • AVDL $18.57
  • ROG $86.18
  • Analyst Decision
  • AVDL Buy
  • ROG Strong Buy
  • Analyst Count
  • AVDL 10
  • ROG 2
  • Target Price
  • AVDL $18.94
  • ROG $85.00
  • AVG Volume (30 Days)
  • AVDL 4.4M
  • ROG 126.0K
  • Earning Date
  • AVDL 11-11-2025
  • ROG 10-29-2025
  • Dividend Yield
  • AVDL N/A
  • ROG N/A
  • EPS Growth
  • AVDL N/A
  • ROG N/A
  • EPS
  • AVDL N/A
  • ROG N/A
  • Revenue
  • AVDL $221,075,000.00
  • ROG $795,800,000.00
  • Revenue This Year
  • AVDL $64.21
  • ROG N/A
  • Revenue Next Year
  • AVDL $30.80
  • ROG $7.80
  • P/E Ratio
  • AVDL N/A
  • ROG N/A
  • Revenue Growth
  • AVDL 132.35
  • ROG N/A
  • 52 Week Low
  • AVDL $6.38
  • ROG $51.43
  • 52 Week High
  • AVDL $18.65
  • ROG $114.05
  • Technical
  • Relative Strength Index (RSI)
  • AVDL 79.97
  • ROG 58.26
  • Support Level
  • AVDL $13.83
  • ROG $83.68
  • Resistance Level
  • AVDL $18.65
  • ROG $86.57
  • Average True Range (ATR)
  • AVDL 0.59
  • ROG 2.38
  • MACD
  • AVDL 0.43
  • ROG -0.00
  • Stochastic Oscillator
  • AVDL 97.93
  • ROG 73.47

About AVDL Avadel Pharmaceuticals plc

Avadel Pharmaceuticals PLC is a specialty pharmaceutical company. The group focused on transforming medicines to transform lives. It provides solutions to the development of medications that address the challenges patients face with current treatment options. The company is engaged in the development of differentiated drug products for administration in various forms such as capsules, tablets, injectables etc. Its commercialized product LUMRYZ is an extended-release formulation of sodium oxybate indicated to be taken once at bedtime for the treatment of cataplexy or EDS in adults with narcolepsy. It operates in one segment, the development and commercialization of pharmaceutical products, including controlled-release therapeutic products based on its proprietary polymer-based technology.

About ROG Rogers Corporation

Rogers Corporation designs develop and manufacture engineered materials and components for sale to original equipment manufacturers and component suppliers. The firm operates in three business segments: Advanced Electronics Solutions, which manufactures circuit materials for applications in communications infrastructure, automotive, and consumer electronics markets; elastomeric material solutions, which provide cushioning, sealing, and impact protection in automotive, transportation, and construction applications; and Other, which consists of elastomer components for applications in the general industrial market, as well as elastomer floats for level sensing in fuel tanks, motors, and storage tanks applications in the general industrial and automotive markets.

Share on Social Networks: